Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, announces a European Union award of EUR 6 million to support MitoCare, a 2.5 year international, translational medicine project. MitoCare, which will begin in January 2011, will be conducted by a 16 partner consortium and led by Trophos. MitoCare forms part of the Seventh Framework Programme of the European Community for Research, Technological Development and Demonstration Activities (FP7)...
More...
More...